Skip to content

New Horizon Aircraft HOVR Other Research And Development Expense

Other Research And Development Expense at other companies

OS Therapies logo
OS TherapiesOSTX
$0
CTO
Citius Oncology, Inc.CTOR
$469K-2.3%
Celanese Corporation logo
Celanese CorporationCE
$0
Corvex
 logo
Corvex MOVE
$899K+12.4%
RFL
Rafael Holdings, Inc.RFL
$22K-51.1%
Comstock Inc. logo
Comstock Inc.LODE
$0-100%

Other financials

Income statement

See full
Operating income-$7.6M-114%
Net income-$6.9M-39.6%
EPS (diluted)-$0.16+5.9%

Balance sheet

See full
Cash & equivalents$19.7M+114%
Total debt$89.0K+154%
Total equity$14.1M+102%
Total assets$21.9M+112%

Cash flow

See full
Operating cash flow-$6.8M-160%
CapEx$140.0K+53.8%
Free cash flow-$7.0M-156%

Valuation

See full
Market cap$119.82M+153%
Enterprise value$100.24M+151%

Returns & leverage

See full
Return on equity-297.2%
Debt / equity0.0×
Current ratio14.8×+7.7×

Where this comes from

Reported directly by New Horizon Aircraft in its filing.

Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.

The official record: New Horizon Aircraft’s 10-K, filed August 22, 2025, on SEC EDGAR. View the filing →

Ask your AI about New Horizon Aircraft's other research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is New Horizon Aircraft's other research and development expense?
New Horizon Aircraft (HOVR) reported other research and development expense of $17.5K in Q1 2025.
How has New Horizon Aircraft's other research and development expense changed year-over-year?
New Horizon Aircraft's other research and development expense increased by 141.4% year-over-year, from $7.25K to $17.5K.
What does other research and development expense mean?
Captures R&D-related expenditures that are not classified under primary research or development categories, such as specialized testing, regulatory compliance, or secondary technical studies. This metric is essential for understanding the full scope of innovation investment beyond core product development. It helps assess the company's commitment to long-term technological advancement.